Brief: Clinical Laserthermia Systems Announces Initiation Of Prostate Cancer Clinical Study
Nov 7 (Reuters) - Clinical Laserthermia Systems AB
CLSRb.ST :
* CLINICAL LASERTHERMIA SYSTEMS ANNOUNCES INITIATION OF
PROSTATE
CANCER CLINICAL STUDY IN COLLABORATION WITH U.S BASED HALO
DIAGNOSTICS
* US SUBSIDIARY CLS AMERICAS AND US BASED HALO DIAGNOSTICS
HAS
ENTERED AGREEMENT TO INITIATE CLINICAL STUDY
Source text for Eikon: ID:nWkr3LjDdM
Further company coverage: CLSRb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Clinical Laserthermia Systems AB
See all newsBrief: CLS Enters Research Agreement With U.S. National Cancer Institute
Sweden's CLS Q1 sales fall 72% after partner talks
Brief: Clinical Laserthermia Systems Q1 EBIT Sek 1.7 Mln
Brief: CLS Receives Order Worth SEK 23 Mln For Prism Business
Brief: CLS Expects To Achieve Positive Cash Flow From Q4 2026 To Q1 2028